FDA Committed To Third-Party Review, Henney Tells Senate HELP Committee
This article was originally published in The Gray Sheet
Executive Summary
FDA Commissioner Jane Henney is "puzzled" about the low utilization rate within the device industry of the agency's "Accredited Persons" third-party premarket review program, she said at an Oct. 21 Senate Health, Education, Labor and Pensions Committee hearing.
You may also be interested in...
User Fees In Administration's Budget Request Aimed At Third-Party Program
FDA's Center for Devices and Radiological Health is hoping that the most recent user fee proposal set forth in the administration's FY 2001 budget request might breathe some life into the agency's moribund 510(k) third-party review program.
User Fees In Administration's Budget Request Aimed At Third-Party Program
FDA's Center for Devices and Radiological Health is hoping that the most recent user fee proposal set forth in the administration's FY 2001 budget request might breathe some life into the agency's moribund 510(k) third-party review program.
CDRH QSIT Team Considers Third-Party Audit Option To Level 1 Inspections
Firms with a good compliance history may be eligible to submit third-party auditing certifications in lieu of biennial FDA inspections, according to a proposal being drafted for consideration by the Center for Devices and Radiological Health's quality systems inspection technique (QSIT) reengineering team.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: